Ross F Harrison1, Yao Li2, Alexis Guzman3, Brandelyn Pitcher4, Andrea Rodriguez-Restrepo5, Katherine E Cain6, Maria D Iniesta1, Javier D Lasala5, Pedro T Ramirez1, Larissa A Meyer7. 1. Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. 2. Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, TX. 3. Department of Clinical Revenue and Reimbursement, The University of Texas MD Anderson Cancer Center, Houston, TX. 4. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. 5. Department of Anesthesiology and Perioperative Medicine, Division of Anesthesiology and Critical Care, The University of Texas MD Anderson Cancer Center, Houston, TX. 6. Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX. 7. Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: lmeyer@mdanderson.org.
Abstract
BACKGROUND: Enhanced recovery programs have been associated with improved outcomes after gynecologic surgery. There are limited data on the effect of enhanced recovery programs on healthcare costs or healthcare service use. OBJECTIVE: The purpose of this study was to evaluate differences in hospital charges for women who undergo surgery for a suspected gynecologic cancer that is managed in an enhanced recovery program as compared with conventional perioperative care. STUDY DESIGN: We performed a retrospective cohort study of women who underwent open abdominal surgery for a suspected gynecologic cancer before and after the implementation of an enhanced recovery after surgery program. Consecutive patients from May to October 2014 and from November 2014 to November 2015 comprised the conventional perioperative care (before enhanced recovery after surgery) and enhanced recovery after surgery cohorts, respectively. Patients were excluded if they underwent surgery with a multidisciplinary surgical team or minimally invasive surgery. All technical and professional charges were ascertained for all healthcare services from the day of surgery until postoperative day 30. Charges for adjuvant treatment were excluded. Charges were classified according to the type of clinical service provided. The primary outcome was the difference in total hospital charges between the pre-enhanced recovery after surgery and the enhanced recovery after surgery groups. Secondary outcomes were between group differences in hospital charges within clinical service categories. RESULTS: A total of 271 patients were included in the analysis (58 patients in the pre-enhanced recovery after surgery and 213 patients in the enhanced recovery after surgery cohort). A total of 70,177 technical charges and 6775 professional charges were identified and classified. The median hospital charge for a patient decreased 15.6% in the enhanced recovery after surgery group compared with the pre-enhanced recovery after surgery group (95% confidence interval, 5-24.5%; P=.008). Patients in the enhanced recovery after surgery group also had lower charges for laboratory services (20% lower; 95% confidence interval, 0--39%; P=.04), pharmacy services (30% lower; 95% confidence interval, 14--41%; P<.001), room and board (25% lower; 95% confidence interval, 20--47%; P=.005), and material goods (64% lower; 95% confidence interval, 44--81%; P<.001). No differences in charges were observed for perioperative services, diagnostic procedures, emergency department care, transfusion-related services, interventional radiology procedures, physical/occupational therapy, outpatient care, or other services. CONCLUSION: Hospital charges and healthcare service use were lower for enhanced recovery patients compared with patients who received conventional perioperative care after open surgery for a suspected gynecologic cancer. Enhanced recovery programs may be considered to be high value in healthcare because they provide improved outcomes while lowering resource use.
BACKGROUND: Enhanced recovery programs have been associated with improved outcomes after gynecologic surgery. There are limited data on the effect of enhanced recovery programs on healthcare costs or healthcare service use. OBJECTIVE: The purpose of this study was to evaluate differences in hospital charges for women who undergo surgery for a suspected gynecologic cancer that is managed in an enhanced recovery program as compared with conventional perioperative care. STUDY DESIGN: We performed a retrospective cohort study of women who underwent open abdominal surgery for a suspected gynecologic cancer before and after the implementation of an enhanced recovery after surgery program. Consecutive patients from May to October 2014 and from November 2014 to November 2015 comprised the conventional perioperative care (before enhanced recovery after surgery) and enhanced recovery after surgery cohorts, respectively. Patients were excluded if they underwent surgery with a multidisciplinary surgical team or minimally invasive surgery. All technical and professional charges were ascertained for all healthcare services from the day of surgery until postoperative day 30. Charges for adjuvant treatment were excluded. Charges were classified according to the type of clinical service provided. The primary outcome was the difference in total hospital charges between the pre-enhanced recovery after surgery and the enhanced recovery after surgery groups. Secondary outcomes were between group differences in hospital charges within clinical service categories. RESULTS: A total of 271 patients were included in the analysis (58 patients in the pre-enhanced recovery after surgery and 213 patients in the enhanced recovery after surgery cohort). A total of 70,177 technical charges and 6775 professional charges were identified and classified. The median hospital charge for a patient decreased 15.6% in the enhanced recovery after surgery group compared with the pre-enhanced recovery after surgery group (95% confidence interval, 5-24.5%; P=.008). Patients in the enhanced recovery after surgery group also had lower charges for laboratory services (20% lower; 95% confidence interval, 0--39%; P=.04), pharmacy services (30% lower; 95% confidence interval, 14--41%; P<.001), room and board (25% lower; 95% confidence interval, 20--47%; P=.005), and material goods (64% lower; 95% confidence interval, 44--81%; P<.001). No differences in charges were observed for perioperative services, diagnostic procedures, emergency department care, transfusion-related services, interventional radiology procedures, physical/occupational therapy, outpatient care, or other services. CONCLUSION: Hospital charges and healthcare service use were lower for enhanced recovery patients compared with patients who received conventional perioperative care after open surgery for a suspected gynecologic cancer. Enhanced recovery programs may be considered to be high value in healthcare because they provide improved outcomes while lowering resource use.
Authors: Jeanny J A de Groot; Stephanie M C Ament; José M C Maessen; Cornelis H C Dejong; Jos M P Kleijnen; Brigitte F M Slangen Journal: Acta Obstet Gynecol Scand Date: 2015-12-21 Impact factor: 3.636
Authors: Alexander B Stone; Michael C Grant; Claro Pio Roda; Deborah Hobson; Timothy Pawlik; Christopher L Wu; Elizabeth C Wick Journal: J Am Coll Surg Date: 2016-01-07 Impact factor: 6.113
Authors: Ester Miralpeix; Alpa M Nick; Larissa A Meyer; Juan Cata; Javier Lasala; Gabriel E Mena; Vijaya Gottumukkala; Maria Iniesta-Donate; Gloria Salvo; Pedro T Ramirez Journal: Gynecol Oncol Date: 2016-03-09 Impact factor: 5.482
Authors: Gregg Nelson; Lawrence N Kiyang; Ellen T Crumley; Anderson Chuck; Thanh Nguyen; Peter Faris; Tracy Wasylak; Carlota Basualdo-Hammond; Susan McKay; Olle Ljungqvist; Leah M Gramlich Journal: World J Surg Date: 2016-05 Impact factor: 3.352
Authors: Lawrence Lee; Juan Mata; Gabriela A Ghitulescu; Marylise Boutros; Patrick Charlebois; Barry Stein; A Sender Liberman; Gerald M Fried; Nancy Morin; Franco Carli; Eric Latimer; Liane S Feldman Journal: Ann Surg Date: 2015-12 Impact factor: 12.969
Authors: Larissa A Meyer; Javier Lasala; Maria D Iniesta; Alpa M Nick; Mark F Munsell; Qiuling Shi; Xin Shelley Wang; Katherine E Cain; Karen H Lu; Pedro T Ramirez Journal: Obstet Gynecol Date: 2018-08 Impact factor: 7.661
Authors: Sarah P Huepenbecker; Maria D Iniesta; Andrés Zorrilla-Vaca; Pedro T Ramirez; Katherine E Cain; Micah Vaughn; Juan P Cata; Gabriel E Mena; Javier Lasala; Larissa A Meyer Journal: Gynecol Oncol Date: 2021-08-13 Impact factor: 5.304
Authors: Ross Harrison; Maria D Iniesta; Brandelyn Pitcher; Pedro T Ramirez; Katherine Cain; Ashley M Siverand; Gabriel Mena; Javier Lasala; Larissa A Meyer Journal: Int J Gynecol Cancer Date: 2020-08-26 Impact factor: 3.437
Authors: Dan B Ellis; Aalok Agarwala; Elena Cavallo; Pam Linov; Michael K Hidrue; Marcela G Del Carmen; Rachel Sisodia Journal: BMC Anesthesiol Date: 2021-02-05 Impact factor: 2.217